Actively Recruiting
AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.
Led by Grand Hôpital de Charleroi · Updated on 2026-04-22
210
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research forms part of a continuous quality improvement initiative. It aims to assess patient compliance of oral therapies by artificial intelligence. It could overcome the limitations of current practices and enhance the responsiveness and accuracy of clinical interventions.
CONDITIONS
Official Title
AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older
- Treated for Non-Hodgkin Lymphoma
- Receiving care at the Haematology Department of Grand Hôpital de Charleroi from November 2025 onward
- Able to provide informed consent
You will not qualify if you...
- Patients who do not meet the inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Grand Hôpital de Charleroi
Charleroi, Hainaut, Belgium, 6060
Actively Recruiting
Research Team
M
Marie Detrait, MD, PhD
CONTACT
A
Aline Gillain, MedSciences
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here